ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/01/30 | 2,239 | 2,246 | 2,217 | 2,224 | -17 | -0.8% | 69,900 |
2018/01/29 | 2,234 | 2,265 | 2,234 | 2,241 | +15 | +0.7% | 73,000 |
2018/01/26 | 2,264 | 2,271 | 2,224 | 2,226 | -21 | -0.9% | 66,100 |
2018/01/25 | 2,297 | 2,298 | 2,245 | 2,247 | -41 | -1.8% | 60,700 |
2018/01/24 | 2,295 | 2,306 | 2,284 | 2,288 | -8 | -0.3% | 37,400 |
2018/01/23 | 2,300 | 2,318 | 2,290 | 2,296 | +2 | +0.1% | 51,400 |
2018/01/22 | 2,292 | 2,295 | 2,268 | 2,294 | +5 | +0.2% | 64,700 |
2018/01/19 | 2,273 | 2,304 | 2,264 | 2,289 | +19 | +0.8% | 131,500 |
2018/01/18 | 2,292 | 2,298 | 2,265 | 2,270 | -24 | -1% | 153,600 |
2018/01/17 | 2,302 | 2,305 | 2,270 | 2,294 | -19 | -0.8% | 108,400 |
2018/01/16 | 2,312 | 2,314 | 2,296 | 2,313 | +1 | ±0% | 60,200 |
2018/01/15 | 2,310 | 2,318 | 2,290 | 2,312 | +8 | +0.3% | 62,800 |
2018/01/12 | 2,319 | 2,319 | 2,292 | 2,304 | -23 | -1% | 88,600 |
2018/01/11 | 2,295 | 2,327 | 2,277 | 2,327 | +19 | +0.8% | 112,800 |
2018/01/10 | 2,240 | 2,348 | 2,222 | 2,308 | +124 | +5.7% | 452,000 |
2018/01/09 | 2,210 | 2,214 | 2,176 | 2,184 | -9 | -0.4% | 46,900 |
2018/01/05 | 2,214 | 2,219 | 2,174 | 2,193 | -14 | -0.6% | 64,800 |
2018/01/04 | 2,182 | 2,208 | 2,180 | 2,207 | +51 | +2.4% | 58,000 |
2017/12/29 | 2,157 | 2,168 | 2,145 | 2,156 | +5 | +0.2% | 27,600 |
2017/12/28 | 2,186 | 2,186 | 2,150 | 2,151 | -13 | -0.6% | 35,400 |
2017/12/27 | 2,187 | 2,188 | 2,164 | 2,164 | -21 | -1% | 32,400 |
2017/12/26 | 2,205 | 2,212 | 2,182 | 2,185 | -19 | -0.9% | 50,600 |
2017/12/25 | 2,201 | 2,207 | 2,181 | 2,204 | +16 | +0.7% | 42,600 |
2017/12/22 | 2,183 | 2,190 | 2,171 | 2,188 | +12 | +0.6% | 53,100 |
2017/12/21 | 2,177 | 2,179 | 2,160 | 2,176 | -7 | -0.3% | 36,000 |
2017/12/20 | 2,200 | 2,200 | 2,178 | 2,183 | -14 | -0.6% | 31,500 |
2017/12/19 | 2,227 | 2,227 | 2,189 | 2,197 | -21 | -0.9% | 41,200 |
2017/12/18 | 2,211 | 2,225 | 2,211 | 2,218 | +31 | +1.4% | 52,200 |
2017/12/15 | 2,210 | 2,213 | 2,183 | 2,187 | -38 | -1.7% | 76,700 |
2017/12/14 | 2,230 | 2,238 | 2,209 | 2,225 | +22 | +1% | 59,400 |
2017/12/13 | 2,209 | 2,227 | 2,191 | 2,203 | -7 | -0.3% | 82,800 |
2017/12/12 | 2,188 | 2,254 | 2,188 | 2,210 | +41 | +1.9% | 165,100 |
2017/12/11 | 2,155 | 2,169 | 2,142 | 2,169 | +19 | +0.9% | 72,400 |
2017/12/08 | 2,119 | 2,154 | 2,119 | 2,150 | +27 | +1.3% | 85,300 |
2017/12/07 | 2,077 | 2,126 | 2,073 | 2,123 | +50 | +2.4% | 75,900 |
2017/12/06 | 2,129 | 2,129 | 2,071 | 2,073 | -56 | -2.6% | 101,200 |
2017/12/05 | 2,115 | 2,132 | 2,101 | 2,129 | +5 | +0.2% | 54,600 |
2017/12/04 | 2,165 | 2,166 | 2,123 | 2,124 | -21 | -1% | 58,300 |
2017/12/01 | 2,176 | 2,176 | 2,141 | 2,145 | -25 | -1.2% | 68,800 |
2017/11/30 | 2,140 | 2,177 | 2,131 | 2,170 | +18 | +0.8% | 91,600 |
2017/11/29 | 2,130 | 2,153 | 2,121 | 2,152 | +34 | +1.6% | 63,800 |
2017/11/28 | 2,120 | 2,131 | 2,111 | 2,118 | +14 | +0.7% | 52,200 |
2017/11/27 | 2,102 | 2,121 | 2,100 | 2,104 | +2 | +0.1% | 59,600 |
2017/11/24 | 2,115 | 2,115 | 2,094 | 2,102 | -19 | -0.9% | 59,500 |
2017/11/22 | 2,150 | 2,152 | 2,121 | 2,121 | -16 | -0.7% | 52,300 |
2017/11/21 | 2,131 | 2,154 | 2,131 | 2,137 | -10 | -0.5% | 43,400 |
2017/11/20 | 2,134 | 2,151 | 2,114 | 2,147 | +24 | +1.1% | 63,900 |
2017/11/17 | 2,150 | 2,155 | 2,117 | 2,123 | -10 | -0.5% | 59,100 |
2017/11/16 | 2,104 | 2,142 | 2,083 | 2,133 | +29 | +1.4% | 111,200 |
2017/11/15 | 2,135 | 2,144 | 2,103 | 2,104 | -67 | -3.1% | 102,200 |
1851~
1900
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム